Anti–cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis
✍ Scribed by Ted R. Mikuls; V. Michael Holers; Lezlie Parrish; Kristine A. Kuhn; Doyt L. Conn; Gary Gilkeson; Edwin A. Smith; Diane L. Kamen; Beth L. Jonas; Leigh F. Callahan; Graciela S. Alarcón; George Howard; Larry W. Moreland; S. Louis Bridges Jr.
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 92 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective The evolution of the rheumatoid arthritis (RA)–specific anti–cyclic citrullinated peptide (anti‐CCP) antibody response, as measured by the isotypes of anti‐CCP, has not been described. This study was undertaken to determine anti‐CCP isotype usage in patients with undiffere
## Abstract ## Objective Recent data have shown that the most prominent and longest known genetic risk factors for rheumatoid arthritis (RA), HLA–DRB1 shared epitope alleles, are only associated with RA that is characterized by the presence of antibodies against cyclic citrullinated peptide (anti‐